Results 251 to 260 of about 1,317,192 (351)

A case description of multisystem tuberculosis complicated with diabetes mellitus and pulmonary embolism. [PDF]

Quant Imaging Med Surg
Dai G, Yang X, Du J, Liu J, Shen J, Ma L, Zeng Y.   +6 more
europepmc   +1 more source

PULMONARY EMBOLISM

Annals of Surgery, 1928
openaire   +3 more sources

Hemocompatibility and Long‐Term Outcomes in HeartWare Versus HeartMate II Versus HeartMate 3: Multicenter Real‐World Cohort

Artificial Organs, EarlyView.
Multicenter real‐world cohort (n = 327) comparing LVADs: HeartMate 3 (HM3), HeartMate II (HMII), and HeartWare (HVAD). HM3 showed superior long‐term survival versus legacy devices, driven by fewer hemocompatibility‐related adverse events, especially pump thrombosis and ischemic stroke, while major bleeding was similar across devices.
Hamza H. H. Ben Nasir, Ahmed F. A. Mohammed, Omar Allham, Alish Kolashov, Yusuf Shieba, Lachmandath Tewarie, Bernd Panholzer, Ajay Moza, Assad Haneya, Rashad Zayat   +9 more
wiley   +1 more source

A functionalized method for assessing the risk of adverse events in patients with pulmonary embolism. [PDF]

Front Med (Lausanne)
Sun K, Yu L, Xie Z, Lu H, Wang S.
europepmc   +1 more source

Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension: A Scientific Statement From the American Heart Association

Circulation, 2011
M. Jaff, M. S. Mcmurtry, S. Archer, M. Cushman, N. Goldenberg, S. Goldhaber, J. Jenkins, J. Kline, A. Michaels, P. Thistlethwaite, S. Vedantham, R. White, B. Zierler   +12 more
semanticscholar   +1 more source

Sustainability in Healthcare: The Role of Digital Technologies for Improving Patient Engagement

Business Ethics, the Environment &Responsibility, EarlyView.
ABSTRACT Sustainability in healthcare is getting considerable research attention as systems worldwide tend to balance environmental, social, and economic factors. In this context, digital technologies have demonstrated significant potential to enhance engagement among different consumer groups across various industries.
Francesco Schiavone, Federica Zeuli, Olga Grieva, Octavio Escobar, Fabian Bernhard   +4 more
wiley   +1 more source

Advancements in Pulmonary Embolism Management: Current Approaches and Future Directions. [PDF]

Rev Cardiovasc Med
Banfi C, Montonati C, Ielasi A, Assouline B, Tespili M, Bendjelid K, Giraud R.   +6 more
europepmc   +1 more source

The efficacy and safety of thrombolytic therapy for acute pulmonary embolism in patients with active malignant disease [PDF]

Slobodan Obradović, Boris Džudović, J Matijasevic, Sonja Šalinger-Martinović, Tamara Kovačević-Preradović, V Miloradovic, Irena Mitevska, Bojan Mitrovic, Bojana Subotić, S Kafedzic, Aleksandar Nešković   +10 more
openalex   +1 more source

Comorbidities and mutations including single‐ and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia—A population‐based study

British Journal of Haematology, EarlyView.
In a population‐based cohort of 149 chronic myelomonocytic leukaemia (CMML) patients, multihit TET2 mutation was associated with older age, lower LDH and less leucocytosis. We found no association with autoimmune disease or thrombosis. Patients with multihit TET2 mutation had a significantly longer overall survival than the patients without or with one
Matilda Kjellander Kynning, Ebba Westerberg, Linda Forsell, Maria Creignou, Daniel Moreno Berggren, Bianca Tesi, Elsa Bernard, Elli Papaemmanuil, Yasuhito Nannya, Lucia Cavelier Franco, Davide Valentini, Eva Hellström Lindberg, Seishi Ogawa, Elisabeth Ejerblad, Johanna Ungerstedt   +14 more
wiley   +1 more source